QA: Endonovo Therapeutics INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001528172_2021_Endonovo_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001528172, Endonovo Therapeutics INC

  xvar xval
0 AssetsCurrent 46,187
1 IntangibleAssetsNetIncludingGoodwill 2,559,268
2 PropertyPlantAndEquipmentNet 1,580
3 remainder_Assets 0
4 LiabilitiesCurrent 16,825,821
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 155,000
7 CostOfGoodsAndServicesSold 69,698
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 3,076,585
11 remainder_Revenues 193,508
12 remainder_NetIncome -13,496,136
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,607,035
1 Liabilities 16,980,821
2 Expenses 3,146,283
3 Revenues 193,508
4 StockholdersEquity -14,373,786
5 NetIncome -16,448,911
6 ComprehensiveNetIncome -16,448,911
7 BaseVar 18,211,892
8 EconomicCapitalRatiobeforeLimitedLiability -4.88
9 EconomicCapitalRatio 0.210

Edgar->Model Mapping

Feature Distribution

Change over Time